Our data confirm the relationship between SPN and p53 inactivation and demonstrate that SPN mutation alone is not able to initiate tumorigenesis, but it is a late event that promotes tumor progression and aggressiveness by increasing stemness and the pool of CD44+ CD24- cells. The gene discussed is SPN; the disease is neoplasm.